<DOC>
	<DOCNO>NCT00518687</DOCNO>
	<brief_summary>This study ass efficacy single dose V710 vaccine prevent serious Staphylococcus aureus infection follow elective cardiothoracic surgery . The study also evaluate immune response general safety V710 vaccine .</brief_summary>
	<brief_title>Efficacy , Immunogenicity , Safety Single Dose V710 Adult Patients Scheduled Cardiothoracic Surgery ( V710-003 AM2 )</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Mediastinitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participant schedule undergo cardiothoracic surgery involve full median sternotomy ( include cardiac transplantation surgery ) within 14 60 day vaccination . Female participant reproductive potential require negative urine serum pregnancy test immediately prior study vaccination must use acceptable form birth control . Participants invasive Staphylococcus aureus infection within past 3 month prior study entry . A realistic ( &gt; 50 % ) possibility cardiothoracic surgery necessary sooner 10 day vaccination . Participant plan undergo cardiac transplantation surgery sternal debridement remedy infection result prior cardiothoracic surgery . Participant type ventricularassist device place time study entry . Participant history anaphylaxis vaccine component . Participant receive V710 vaccine , investigational Staphylococcus aureus vaccine , investigational Staphylococcus aureus antibody . Participant temperature ≥100.4ºF ( ≥38.0ºC ) , oral equivalent , within 48 hour prior study vaccination . Participant impairment immune system . Participant medical condition expect survival le 90 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>